Evidence map›Paper›PMID 37101172›Full record

ArticleMolecular cancer2023

Editorial Expression of Concern: Let-7d suppresses growth, metastasis, and tumor macrophage infiltration in renal cell carcinoma by targeting COL3A1 and CCL7.

Boxing Su, Wei Zhao, Bentao Shi, Zhongyuan Zhang, Xi Yu, Feng Xie, Zhongqiang Guo, Xiaoyu Zhang, Jin Liu, Qi Shen and 4 more

Open access · goldAbstract readExpression of Concern
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Acquired resistance to immunotherapy by physical barriers with cancer cell-expressing collagens in non-small cell lung cancer.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Boxing Su *Department of Urology, Peking University First Hospital & the Institute of Urology, Peking University, Beijing, 100034, China.
Wei Zhao *Department of Cell Biology, Peking University School of Oncology, Beijing Cancer Hospital and Institute, Beijing, 100142, China.
Bentao ShiDepartment of Urology, Peking University Shenzhen Hospital, Shenzhen, 518036, Guangdong, China.
Zhongyuan ZhangDepartment of Urology, Peking University First Hospital & the Institute of Urology, Peking University, Beijing, 100034, China.
Xi YuDepartment of Urology, Peking University First Hospital & the Institute of Urology, Peking University, Beijing, 100034, China.
Feng XieDepartment of Urology, Peking University First Hospital & the Institute of Urology, Peking University, Beijing, 100034, China.
Zhongqiang GuoDepartment of Urology, Peking University First Hospital & the Institute of Urology, Peking University, Beijing, 100034, China.
Xiaoyu ZhangDepartment of Urology, Peking University First Hospital & the Institute of Urology, Peking University, Beijing, 100034, China.
Jin LiuDepartment of Urology, Peking University First Hospital & the Institute of Urology, Peking University, Beijing, 100034, China.
Qi ShenDepartment of Urological Pathology, Peking University First Hospital & the Institute of Urology, Peking University, Beijing, 100034, China.
Jinghua WangDepartment of Urological Pathology, Peking University First Hospital & the Institute of Urology, Peking University, Beijing, 100034, China.
Xuesong LiDepartment of Urology, Peking University First Hospital & the Institute of Urology, Peking University, Beijing, 100034, China.
Zhiqian ZhangDepartment of Cell Biology, Peking University School of Oncology, Beijing Cancer Hospital and Institute, Beijing, 100142, China. zlzqzhang@bjmu.edu.cn.
Liqun ZhouDepartment of Urology, Peking University First Hospital & the Institute of Urology, Peking University, Beijing, 100034, China. zhoulqmail@china.com.
Peking University · CNBeijing Chest Hospital · CNPeking University First Hospital · CNPeking University Shenzhen Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37101172
PMCPMC10131359
OpenAlexW4367052216

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.